Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Dive into the basics of zero based budgeting and learn to allocate every dollar effectively. Start budgeting smarter today!
15,768 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Kratos Defense stock just surged after two new contract wins. This article breaks down what happened, why it matters,...
In 2026, certain currencies remain prime targets for counterfeiters as cash circulates globally. Authorities are raci...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...
When the Federal Reserve sends a warning, investors watch closely. This guide breaks down why the stock market sounds...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...
As MercadoLibre broadens beyond e-commerce, the mercado pago growth engine becomes a pivotal piece of the puzzle. Thi...
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
Bitcoin selling pressure weakens as a surge in U.S. spot ETF inflows shows renewed demand. This article breaks down w...
Software stocks bounce Nvidia falters as investors rotate from AI-chip names to durable software franchises, signalin...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...